ResMed, Inc. Stock
Stocks
RMD
US7611521078
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
NYSE
16:00:02 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 229.94 USD | -9.05% |
|
-9.06% | -4.54% |
| 10-30 | RBC Raises Price Target on ResMed to $288 From $262, Keeps Outperform Rating | MT |
| 10-30 | Citigroup Adjusts Price Target on ResMed to $270 From $240 | MT |
| Market Cap | 32.34B 28.97B 26.64B 24.14B 45.13B 3,071B 45.97B 318B 128B 1,615B 121B 119B 5,094B | P/E 2027 * |
19.2x | P/E 2028 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 31.4B 28.12B 25.87B 23.44B 43.81B 2,981B 44.63B 308B 124B 1,568B 118B 115B 4,946B | EV / Sales 2027 * |
5.38x | EV / Sales 2028 * | 4.98x |
| Free-Float |
74.65% | Yield 2027 * |
1.17% | Yield 2028 * | 1.27% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RMD | Delayed | |
CBOE
| RMD | Real-time | |
|
Tradegate
| RME | Real-time | |
|
Börse Stuttgart
| RME | Delayed | |
|
Xetra
| RME | Delayed | |
|
Boerse Muenchen
| RME | Real-time | |
|
Wiener Boerse
| RMD | End-of-day quote | |
|
Berne S.E.
| RME | End-of-day quote | |
|
Mexican S.E.
| RMD * | End-of-day quote | |
|
London S.E.
| 0KW4 | Delayed | |
|
Deutsche Boerse AG
| RME | Delayed | |
|
Borsa Italiana
| 1RMD | End-of-day quote |
Last Transcript: ResMed, Inc.
| 1 day | -9.05% | ||
| 1 week | -9.06% | ||
| 1 month | +3.97% | ||
| 3 months | +8.99% | ||
| 6 months | +12.15% | ||
| Current year | -4.54% |
| 1 week | 228.33 |  | 254.27 |
| 1 month | 218.44 | | 255.56 |
| Current year | 180.26 | | 277.67 |
| 1 year | 180.26 | | 277.67 |
| 3 years | 140.81 | | 293.81 |
| 5 years | 132.24 | | 293.81 |
| 10 years | 56.59 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 54 | 2013-02-28 |
Aaron Bloomer
DFI | Director of Finance/CFO | 41 | 2026-05-03 |
| Chief Tech/Sci/R&D Officer | - | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 2004-12-31 |
Mick Farrell
CHM | Chairman | 54 | 2023-01-24 |
Peter Farrell
CHM | Chairman | 84 | 1989-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/7/26 | Exercice | Chief Executive Officer | 14,973 | 0.0104% | ||
| 9/8/26 | Exercice | Chief Executive Officer | 14,973 | 0.0104% | ||
| 9/8/26 | Other | Chief Executive Officer | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.05% | -9.06% | -6.86% | +56.23% | 32.34B | |
| -1.72% | +3.44% | +22.84% | +58.01% | 258B | |
| -2.00% | +0.75% | +7.82% | +22.23% | 163B | |
| -3.73% | -4.48% | -19.14% | +59.73% | 150B | |
| -1.66% | -8.12% | -58.32% | -18.74% | 60.84B | |
| -.--% | +2.46% | -11.69% | -7.86% | 53.31B | |
| -2.57% | +3.30% | +11.59% | +44.15% | 53.03B | |
| +0.84% | -3.12% | +7.47% | +67.31% | 50.67B | |
| -3.47% | +1.04% | +19.48% | +70.01% | 49.3B | |
| -3.61% | +1.99% | +32.36% | +92.13% | 45.46B | |
| Average | -2.70% | -1.18% | +0.56% | +44.32% | 91.63B | |
| Weighted average by Cap. | -2.35% | -0.17% | +3.65% | +44.97% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 5.83B 5.23B 4.81B 4.36B 8.14B 554B 8.29B 57.32B 23.01B 291B 21.9B 21.43B 919B | 6.2B 5.55B 5.11B 4.63B 8.65B 589B 8.81B 60.9B 24.45B 310B 23.26B 22.77B 976B |
| Net income | 1.69B 1.51B 1.39B 1.26B 2.35B 160B 2.4B 16.58B 6.65B 84.27B 6.33B 6.2B 266B | 1.82B 1.63B 1.5B 1.36B 2.53B 172B 2.58B 17.84B 7.16B 90.69B 6.81B 6.67B 286B |
| Net Debt | -943M -845M -777M -704M -1.32B -89.55B -1.34B -9.27B -3.72B -47.11B -3.54B -3.46B -149B | -1.5B -1.34B -1.23B -1.12B -2.09B -142B -2.13B -14.72B -5.91B -74.85B -5.62B -5.5B -236B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$229.94 | -9.05% | 3,470,544 |
| 26-10-29 | US$252.83 | +1.06% | 1,450,972 |
| 26-10-28 | US$250.17 | -0.25% | 1,020,371 |
| 26-10-27 | US$250.80 | -0.95% | 936,664 |
| 26-10-26 | US$253.20 | +0.13% | 1,074,677 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
